Fitzgerald Kevin Joseph

EDGAR CIK 0001886431

Alnylam Pharmaceuticals, Inc. - ALNY

Officer
CSO & EVP, Head of Research
Direct Buys
0
$0
0 Shares
Direct Sells
9
($5.21) M
-14,888 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
02/17/2026
10b5-1
02/17/2026
Sell
-2,041 @ $331.96
($677,532) 21,264 (-8.76%) Direct
02/13/2026
02/17/2026
Sell
-1,959 @ $310.08
($607,448) 23,305 (-7.75%) Direct
01/13/2026
10b5-1
01/14/2026
Sell
-2,290 @ $370.33
($848,065) 21,264 (-9.72%) Direct
01/12/2026
01/14/2026
Sell
-1,510 @ $362.87
($547,927) 23,554 (-6.02%) Direct
10/02/2025
10/03/2025
Sell
-2,441 @ $452.05
($1,103,451) 25,231 (-8.82%) Direct
08/18/2025
08/19/2025
Sell
-1,396 @ $453.27
($632,759) 22,719 (-5.79%) Direct
03/04/2025
10b5-1
03/05/2025
Sell
-844 @ $241.15
($203,532) 13,501 (-5.88%) Direct
03/03/2025
10b5-1
03/05/2025
Sell
-1,911 @ $243.73
($465,772) 14,345 (-11.76%) Direct
02/28/2025
03/03/2025
Sell
-496 @ $241.69
($119,878) 12,385 (-3.85%) Direct